Ilex Medical Ltd (TLV:ILX)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
6,025.00
-10.00 (-0.17%)
Aug 5, 2025, 9:59 AM IDT
-0.17%
Market Cap674.08M
Revenue (ttm)922.08M
Net Income (ttm)34.17M
Shares Out11.19M
EPS (ttm)3.05
PE Ratio17.20
Forward PEn/a
Dividend1.22 (2.02%)
Ex-Dividend DateApr 7, 2025
Volume1
Average Volume7,685
Open6,025.00
Previous Close6,025.00
Day's Range6,025.00 - 6,025.00
52-Week Range5,643.00 - 8,499.00
Beta-0.14
RSI44.03
Earnings DateAug 24, 2025

About Ilex Medical

Ilex Medical Ltd provides healthcare technological solutions in Israel, South Africa, and internationally. The company offers microbiology, chemistry, molecular biology, immunochemistry, and blood banking solutions. It also offers coagulation, hematology, blood gases, bilirubin, biomarkers, fertility, cellular medicine occult blood, and calprotectin services, as well as provides LIS, urine microscopy, osmolarity, and genetic laboratory services. In addition, the company offers medical automation solutions for microbiology, immunoserology, chemi... [Read more]

Sector Healthcare
Founded 1977
Employees 178
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol ILX
Full Company Profile

Financial Performance

In 2024, Ilex Medical's revenue was 920.37 million, an increase of 0.45% compared to the previous year's 916.25 million. Earnings were 38.98 million, a decrease of -23.39%.

Financial Statements

News

There is no news available yet.